READ THE NEWS ON ONE CLICK
http://www.theoneclickgroup.co.uk
1. Drug Dealers Panic - The British Swine Flu Disaster
LONDON — Swine flu is far less dangerous than originally feared, British officials said. Earlier this week, American researchers released a similar analysis of the virus and said swine flu, or H1N1, may turn out to be the mildest pandemic on record. Most people who catch swine flu have mild symptoms like a fever or cough, and recover without needing medical treatment. In Britain, Tamiflu is largely dispensed by call center workers at a national swine flu hotline who have no medical training. One Click Note: In the recent Budget, the Department of Health has been told it must make cuts worth £10bn-a-year by 2102-13. And just precisely how many squandered billions of our money have they all spent on pharmaceutical industry empire building with Swine Flu we ask?
Maria Cheng, Associated Press
Related Links:
* World Health Organisation ‘Mr Swine Flu’ Under Investigation For Gross Conflict Of Interest
F. William Engdahl, Market Oracle
* Wikileaks Publishes Confidential Reports - Pharma Inside The WHO
Information Release, Wikileaks
* British Government Swine Flu Mishandling Wrecks Economy
Daniel Martin, Daily Mail
* UK Government Spent £500 Million On Tamiflu That Doesn't Work
Victoria Fletcher, Daily Express
* Britons Refuse Deadly Swine Flu Shot - Vaccines Basil Et Al Bribe Doctors To Inject 90m Doses
Andrew Jack, Financial Times
* UK Drugs Dealer Supremo Squanders £1billion Plus On Swine Flu
Jeremy Laurance, The Independent / The One Click Group
* GlaxoSmithKline - No Explanation For Canada Killer H1N1 Vaccine
Helen Branswell, Medical Reporter, Canadian Press
2. Novartis Is Celebrating. Should We?
Dr Meryl Nass, MD
From Dr. Sherri Tenpenny in the Dec. 8, 2009 Huffington Post: On November 24, 2009, Novartis officially opened its first, large-scale vaccine manufacturing facility in the U.S. The project is a collaborative effort between Novartis and the U.S. Department of Health and Human Services, which contributed $457M. Even though its use has not been approved by U.S. regulators, the plant will be producing MF59 as early as December 2009.(2) MF59 is Novartis' proprietary and controversial adjuvant composed of squalene and a surfactant called Tween80, also known as polysorbate 80. Back in July, 2009, the department of HHS purchased over $343.8M of "oil-in-water" adjuvant from Norvartis.(3) It looks like the government may want to take delivery on its purchase some time soon. The new plant will provide something different. Vaccines will be brewed from animal cells mixed with viruses in six 1,320 gallon fermenters which are owned by the U.S. government and the Department of HHS, as identified by a bright yellow, plastic plaque on the sides of the giant vats.
Dr Meryl Nass, MD, from Sheri Tenpenny, Huffington Post
READ THE NEWS ON ONE CLICK
http://www.theoneclickgroup.co.uk
Posts
